THEON Enters into Exclusivity Agreement for the Acquisition of HGH Systèmes Infrarouges, Accelerating Expansion into Multi-Domain ISR & Counter-UAS Solutions (opens original article in a new tab)

THEON agrees to acquire HGH Systèmes Infrarouges for €300 million, enhancing its defense technology portfolio with AI-driven ISR and counter-UAS solutions. The deal is expected to boost THEON's profitability and expand its presence in France as an export hub and AI R&D center.

• THEON enters exclusivity agreement to acquire HGH Systèmes Infrarouges for €300 million
• Acquisition expands THEON's Multi-Domain ISR and counter-UAS solutions with HGH's AI-driven technology
• Deal expected to be EBITDA margin accretive and mid-single-digit EPS accretive in 2027
• HGH has €40 million in revenues with 30% CAGR since 2023 and 40% EBITDA margins